October 28, 2010 (Chicago, Illinois) — LIPO-102 injections quantifiably reduced abominable fat, assessed by the Canfield VECTRA 3D system. The results of a phase 2 trial of LIPO-102 were reported by ...
Marketing Approval Expands Treatment to Include Nearly 11 Million Patients Who Experience Opioid-Induced Constipation While Taking Opioids for Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- ...
Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s pivotal phase 3 study (CBL-0301 phase 3) for subcutaneous fat ...
Injection site reactions are the most common side effect of Emgality. The most frequent injection site reaction is pain. But there are steps you can take to help prevent or reduce pain from Emgality ...
The subcutaneous route allows drugs such as insulin and heparin to be absorbed slowly over a period of time. Using the correct injection technique and selecting the correct site will minimise the risk ...
Injectable forms of medication may benefit patients with blood cancers. MARIEBETH HEROFF, who is living with multiple myeloma, continued working full time thanks to few side effects. - PHOTO BY ALY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback